Systemic complement activation levels in Stargardt disease

PURPOSE: Preclinical research provides evidence for the complement system as a potential common pathway in Stargardt disease (STGD1) and age-related macular degeneration (AMD) leading to retinal pigment epithelium (RPE) loss. However, systemic complement activation has not yet been assessed in STGD1...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:PLoS One
Asıl Yazarlar: Dhooge, Patty P. A., Runhart, Esmee H., Li, Catherina H. Z., de Kat Angelino, Corrie M., Hoyng, Carel B., van der Molen, Renate G., den Hollander, Anneke I.
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Public Library of Science 2021
Konular:
Research Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC8232401/
https://ncbi.nlm.nih.gov/pubmed/34170959
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0253716
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller